Search research articles
Contact Us
Filters
Showing results (181-190 of 192) with videos related to
Page
of 20
Sort By:
The European Respiratory Journal
|
April 1, 2022
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
Kohei Otsubo, Junji Kishimoto, Masahiko Ando, et al.
JCI Insight
|
April 7, 2022
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
Kentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
Thoracic Cancer
|
June 3, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study
Keijiro Yamauchi, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Frontiers in Immunology
|
July 30, 2024
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study
Naoya Nishioka, Hayato Kawachi, Tadaaki Yamada, et al.
Scientific Reports
|
March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
Daichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
JTO Clinical and Research Reports
|
October 27, 2025
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLC
Kensuke Kanaoka, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial
Daichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2022
Histologic transformation of epidermal growth factor receptor-mutated lung cancer
Daichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting
Ryosuke Tsugitomi, Kento Takagi, Go Saito, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2026
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer
Kinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 192) with videos related to
Sort By:
Page
of 20
The European Respiratory Journal
|
April 1, 2022
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
Kohei Otsubo, Junji Kishimoto, Masahiko Ando, et al.
JCI Insight
|
April 7, 2022
Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
Kentaro Masuhiro, Motohiro Tamiya, Kosuke Fujimoto, et al.
Thoracic Cancer
|
June 3, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study
Keijiro Yamauchi, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Frontiers in Immunology
|
July 30, 2024
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study
Naoya Nishioka, Hayato Kawachi, Tadaaki Yamada, et al.
Scientific Reports
|
March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
Daichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
JTO Clinical and Research Reports
|
October 27, 2025
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLC
Kensuke Kanaoka, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 3, 2026
Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial
Daichi Fujimoto, Mitsuhiro Abe, Kenta Murotani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2022
Histologic transformation of epidermal growth factor receptor-mutated lung cancer
Daichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting
Ryosuke Tsugitomi, Kento Takagi, Go Saito, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2026
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer
Kinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, et al.
Page
of 20